The Jackson Laboratory (often abbreviated as JAX) is an independent, non-profit biomedical research institution. It employs more than 2,100 employees in Bar Harbor, Maine; Sacramento, California; and a genomic medicine institute in Farmington, Connecticut. The institution is a National Cancer Institute-designated Cancer Center and has NIH Centers of Excellence in aging and systems genetics.[citation needed]The laboratory is also the world's source for more than 8,000 strains of genetically defined mice, home of the Mouse Genome Informatics database and is an international hub for scientific courses, conferences, training and education.
Glutathione is a ubiquitous antioxidant with critical roles in xenobiotic clearance and aerobic metabolism. Reduced glutathione (GSH) is converted to its oxidized counterpart, GSSG, in the process of neutralizing free radicals and maintaining biochemical homeostasis. An imbalance between free radical generation and antioxidant protection leads to oxidative stress and diminished GSH concentrations. Polymorphisms in GSH synthesis and metabolism genes have been associated with cardiovascular disease (CVD) development and progression, highlighting the critical need to explore the link between GSH system genetics and CVD. While those prior studies have focused on canonical GSH genes such as glutathione peroxidases (GPx), few studies to this date have investigated whether genes outside of traditional GSH pathways may be impacting the cardiac GSH redox system. Here, we performed high-precision genetic mapping using the Diversity Outbred (DO) mouse stock which revealed novel loci and genes underlying the cardiac GSH system. Mapping results indicated a locus on murine chromosome 14 at 54.240 Mbp associated with cardiac GSH concentrations, and bioinformatics analyses delineated five potential candidate genes: Slc7a7, Myh6, Myh7, MiR-208a, and Nfatc4. In addition, statistical analyses revealed notable variation in the cardiac GSH redox system under normal physiological conditions and correlations between cardiac and renal GSH phenotypes in the same cohort of mice. Overall, these findings expand our current knowledge of the vital GSH system, reveal novel genetic regulation of cardiac GSH status, and present candidate genes to be tested in future mechanistic studies.
The RSNA Lumbar Degenerative Imaging Spine Classification dataset is the largest publicly available adult MRI lumbar spine dataset for degenerative disease. The dataset includes multisequence, multiplanar MRIs from 2,697 patients through contributions from 8 institutions across 6 countries and 5 continents. ©RSNA, 2026.
Although certain substances exist in the environment at trace concentrations, their ecological risks remain significant, making nontarget screening (NTS) one of the most important topics in the fields of environmental and analytical chemistry today. In recent years, with the development of high-resolution mass spectrometry (HRMS), the higher precision and accuracy have provided mass spectrometry (MS) characteristics with deeper application significance, offering new perspectives for NTS. This review briefly introduces the principles and methodologies of different MS characteristics and summarizes emerging advancements in screening strategies based on these characteristics. We innovatively propose a target-nontarget to nontarget screening workflow, which links different MS characteristics to achieve comprehensive NTS. This workflow prioritizes the currently applied MS characteristics, aiming to integrate various analytical steps to expand the screening coverage while maintaining reliability. The prioritization includes 1) mass defect (MD) analysis, 2) isotope patterns, 3) characteristic fragments, 4) construction of MS characteristics through chemical reactions, and 5) intermolecular connectivity MS characteristics mining. Subsequently, we provided an overview of the mining and prediction of MS characteristics based on machine learning. Finally, we evaluated the challenges of transitioning from target-nontarget to nontarget workflows and proposed future perspectives for NTS.
Neurodegenerative diseases affect 1 in 12 people globally and remain incurable. Central to their pathogenesis is a loss of neuronal protein maintenance and the accumulation of protein aggregates with ageing1,2. Here we engineered bioorthogonal tools3 that enabled us to tag the nascent neuronal proteome and study its turnover with ageing, its propensity to aggregate and its interaction with microglia. We show that neuronal protein half-life approximately doubles on average between 4-month-old and 24-month-old mice, with the stability of individual proteins differing among brain regions. Furthermore, we describe the aged neuronal 'aggregome', which encompasses 1,726 proteins, nearly half of which show reduced degradation with age. The aggregome includes well-known proteins linked to diseases and numerous proteins previously not associated with neurodegeneration. Notably, we demonstrate that neuronal proteins accumulate in aged microglia, with 54% also displaying reduced degradation and/or aggregation with age. Among these proteins, synaptic proteins are highly enriched, which suggests that there is a cascade of events that emerge from impaired synaptic protein turnover and aggregation to the disposal of these proteins, possibly through microglial engulfment of synapses. These findings reveal the substantial loss of neuronal proteome maintenance with ageing, which could be causal for age-related synapse loss and cognitive decline.
Identifying the causal variants and mechanisms that drive complex traits and diseases remains a core problem in human genetics1-5. Most of these variants individually have weak effects6 and lie in non-coding gene-regulatory elements7-10, for which we lack a complete understanding of how single-nucleotide alterations modulate transcriptional processes to affect human phenotypes5,11-15. To address this problem, we measured the activity of 221,412 fine-mapped trait-associated variants using a massively parallel reporter assay16-20 in 5 diverse cell types. We show that this assay effectively discriminates between likely causal variants and controls, and identified 13,121 regulatory variants with high precision. Although the effects of these variants largely agree with orthogonal measures of function, only 69% of them can plausibly be explained by the disruption of a known transcription factor binding motif. We investigated the mechanisms of 136 variants using saturation mutagenesis and assigned affected transcription factors for 91% of variants without a clear canonical mechanism. Finally, we detected regulatory epistasis at 11% of tested regulatory variants in close proximity and identified multiple functional variants on the same haplotype at a small, but important, subset of trait-associated loci. Overall, our study provides a systematic functional characterization of likely causal common variants that underlie complex and molecular human traits, enabling new insights into the regulatory grammar underlying disease risk.